These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 20922440

  • 1. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis.
    Kenawy N, Cleary G, Mewar D, Beare N, Chandna A, Pearce I.
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):297-300. PubMed ID: 20922440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
    J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826
    [Abstract] [Full Text] [Related]

  • 5. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ, Dick AD, Lee RJ, Ramanan AV, Carreño E, Guly CM, Ross AH.
    Surv Ophthalmol; 2016 Nov; 61(2):197-210. PubMed ID: 26599495
    [Abstract] [Full Text] [Related]

  • 6. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV, Dick AD, Jones AP, Hughes DA, McKay A, Rosala-Hallas A, Williamson PR, Hardwick B, Hickey H, Rainford N, Hickey G, Kolamunnage-Dona R, Culeddu G, Plumpton C, Wood E, Compeyrot-Lacassagne S, Woo P, Edelsten C, Beresford MW.
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
    Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.
    Br J Ophthalmol; 2016 Jun; 100(6):782-6. PubMed ID: 26396026
    [Abstract] [Full Text] [Related]

  • 8. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
    Adán A, Mesquida M, Llorenç V, Espinosa G, Molins B, Hernández MV, Pelegrín L.
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
    [Abstract] [Full Text] [Related]

  • 9. Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
    Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.
    Ocul Immunol Inflamm; 2016 Nov; 24(1):81-90. PubMed ID: 26652068
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F, Balzarin M, Falcini F, Martini G, Alessio M, Cimaz R, Cimino L, Zannin ME.
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [Abstract] [Full Text] [Related]

  • 12. Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis.
    Bauermann P, Heiligenhaus A, Heinz C.
    Ocul Immunol Inflamm; 2019 Jun; 27(8):1232-1234. PubMed ID: 31268748
    [Abstract] [Full Text] [Related]

  • 13. Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
    Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
    Ocul Immunol Inflamm; 2016 Aug; 24(4):386-91. PubMed ID: 26171661
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.
    Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.
    Clin Exp Rheumatol; 2018 Aug; 36(4):652-657. PubMed ID: 29303704
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
    Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R.
    Clin Rheumatol; 2020 Mar; 39(3):847-851. PubMed ID: 31897953
    [Abstract] [Full Text] [Related]

  • 19. Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis.
    Leinonen S, Immonen I, Kotaniemi K.
    Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
    Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1813-6. PubMed ID: 26311261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.